US Stock MarketDetailed Quotes

ITOS ITeos Therapeutics

Watchlist

8.540
+0.350+4.27%

Close Nov 27 16:00 ET

8.540
0.0000.00%

Post 16:20 ET

312.00MMarket Cap-2719P/E (TTM)

ITeos Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-10.21%-37.35M

-14.83%-33.93M

-22.01%-32.4M

6.69%-103.76M

49.34%-13.77M

-14.12%-33.89M

2.56%-29.55M

-10.64%-26.56M

-121.67%-111.19M

53.80%-27.17M

Net income from continuing operations

-40.69%-45.36M

79.22%-7.13M

-145.75%-38.22M

-216.54%-112.64M

-249.37%-30.55M

-3,353.28%-32.24M

-709.67%-34.3M

-122.35%-15.55M

-54.95%96.65M

-88.94%20.45M

Depreciation and amortization

34.82%302K

37.78%310K

36.94%304K

11.83%898K

1.79%227K

9.27%224K

15.38%225K

23.33%222K

33.17%803K

47.68%223K

Other non cash items

---4K

-150.00%-1K

----

0.00%2K

-16.67%10K

50.00%3K

Change In working capital

126.10%1.64M

-32,159.41%-32.38M

106.98%990K

96.15%-8.8M

122.21%11.55M

82.88%-6.27M

100.24%101K

85.52%-14.18M

-180.40%-228.49M

79.02%-52.01M

-Change in receivables

81.09%-574K

-899.36%-37.35M

-78.09%384K

-172.50%-7.32M

-160.62%-2.3M

-249.25%-3.04M

-545.42%-3.74M

-77.38%1.75M

192.72%10.1M

164.71%3.79M

-Change in prepaid assets

92.65%-173K

-269.28%-799K

-209.57%-252K

-68.81%184K

737.85%1.84M

32.37%-2.36M

-81.49%472K

-87.29%230K

105.00%590K

94.75%-288K

-Change in payables and accrued expense

297.27%1.52M

46.77%4.27M

114.61%647K

43.04%8.38M

33,440.63%10.67M

93.17%-768K

110.50%2.91M

-109.88%-4.43M

-52.14%5.86M

-101.08%-32K

-Change in other working capital

881.98%868K

226.09%1.5M

101.80%211K

95.90%-10.04M

102.43%1.35M

99.47%-111K

102.84%460K

92.29%-11.74M

-183.16%-245.03M

76.83%-55.48M

Cash from discontinued investing activities

Operating cash flow

-10.21%-37.35M

-14.83%-33.93M

-22.01%-32.4M

6.69%-103.76M

49.34%-13.77M

-14.12%-33.89M

2.56%-29.55M

-10.64%-26.56M

-121.67%-111.19M

53.80%-27.17M

Investing cash flow

Cash flow from continuing investing activities

-503.16%-91.49M

-18.81%16.32M

-119.60%-69.6M

116.29%72.66M

113.83%61.56M

21,712.38%22.69M

4,011.09%20.1M

-9,712.38%-31.69M

-35,814.81%-446.06M

-276,372.05%-445.12M

Net PPE purchase and sale

87.48%-94K

36.86%-442K

-694.12%-945K

-216.20%-2.97M

-1,093.16%-1.4M

-804.82%-751K

-36.99%-700K

47.58%-119K

20.58%-938K

27.78%-117K

Net investment purchase and sale

-488.47%-91.4M

-19.42%16.76M

-117.43%-68.66M

117.02%75.72M

114.15%62.97M

--23.53M

--20.8M

---31.58M

---445M

Net other investing changes

----

17.50%-99K

-1,700.00%-16K

----

-96.72%-120K

0.00%1K

Cash from discontinued investing activities

Investing cash flow

-503.16%-91.49M

-18.81%16.32M

-119.60%-69.6M

116.29%72.66M

113.83%61.56M

21,712.38%22.69M

4,011.09%20.1M

-9,712.38%-31.69M

-35,814.81%-446.06M

-276,372.05%-445.12M

Financing cash flow

Cash flow from continuing financing activities

-4,520.00%-442K

56,035.78%122.38M

-96.19%22K

-43.90%1.11M

-77.66%307K

1,100.00%10K

-21.58%218K

73.57%578K

-45.78%1.98M

-41.68%1.37M

Net common stock issuance

--0

----

Proceeds from stock option exercised by employees

360.00%46K

992.66%2.38M

-96.19%22K

20.32%1.11M

-2.54%307K

1,100.00%10K

-21.58%218K

73.57%578K

-68.57%925K

-80.79%315K

Net other financing activities

----

47.91%1.06M

----

Cash from discontinued financing activities

Financing cash flow

-4,520.00%-442K

56,035.78%122.38M

-96.19%22K

-43.90%1.11M

-77.66%307K

1,100.00%10K

-21.58%218K

73.57%578K

-45.78%1.98M

-41.68%1.37M

Net cash flow

Beginning cash position

16.13%251.4M

-34.88%146.92M

-11.78%251.45M

-66.42%285.04M

-72.84%204.4M

-72.67%216.48M

-72.63%225.6M

-66.42%285.04M

152.29%848.84M

-16.38%752.47M

Current changes in cash

-1,055.65%-129.28M

1,235.73%104.77M

-76.83%-101.98M

94.60%-29.99M

110.21%48.1M

62.46%-11.19M

69.81%-9.23M

-140.38%-57.67M

-207.70%-555.27M

-731.70%-470.92M

Effect of exchange rate changes

316.20%1.94M

-358.04%-289K

-44.21%-2.55M

57.75%-3.6M

-130.05%-1.05M

90.94%-895K

107.13%112K

-214.56%-1.77M

-168.45%-8.53M

-37.18%3.49M

End cash Position

-39.31%124.05M

16.13%251.4M

-34.88%146.92M

-11.78%251.45M

-72.84%204.4M

-72.67%216.48M

-72.63%225.6M

-66.42%285.04M

Free cash flow

-8.09%-37.45M

-13.63%-34.37M

-25.01%-33.35M

4.82%-106.72M

44.44%-15.16M

-16.33%-34.64M

1.90%-30.25M

-10.09%-26.67M

-121.90%-112.13M

53.73%-27.29M

Currency Unit

USD

Audit Opinions

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-10.21%-37.35M	-14.83%-33.93M	-22.01%-32.4M	6.69%-103.76M	49.34%-13.77M	-14.12%-33.89M	2.56%-29.55M	-10.64%-26.56M	-121.67%-111.19M	53.80%-27.17M
Net income from continuing operations	-40.69%-45.36M	79.22%-7.13M	-145.75%-38.22M	-216.54%-112.64M	-249.37%-30.55M	-3,353.28%-32.24M	-709.67%-34.3M	-122.35%-15.55M	-54.95%96.65M	-88.94%20.45M
Depreciation and amortization	34.82%302K	37.78%310K	36.94%304K	11.83%898K	1.79%227K	9.27%224K	15.38%225K	23.33%222K	33.17%803K	47.68%223K
Other non cash items	---4K	---4K	-150.00%-1K	----	----	----	----	0.00%2K	-16.67%10K	50.00%3K
Change In working capital	126.10%1.64M	-32,159.41%-32.38M	106.98%990K	96.15%-8.8M	122.21%11.55M	82.88%-6.27M	100.24%101K	85.52%-14.18M	-180.40%-228.49M	79.02%-52.01M
-Change in receivables	81.09%-574K	-899.36%-37.35M	-78.09%384K	-172.50%-7.32M	-160.62%-2.3M	-249.25%-3.04M	-545.42%-3.74M	-77.38%1.75M	192.72%10.1M	164.71%3.79M
-Change in prepaid assets	92.65%-173K	-269.28%-799K	-209.57%-252K	-68.81%184K	737.85%1.84M	32.37%-2.36M	-81.49%472K	-87.29%230K	105.00%590K	94.75%-288K
-Change in payables and accrued expense	297.27%1.52M	46.77%4.27M	114.61%647K	43.04%8.38M	33,440.63%10.67M	93.17%-768K	110.50%2.91M	-109.88%-4.43M	-52.14%5.86M	-101.08%-32K
-Change in other working capital	881.98%868K	226.09%1.5M	101.80%211K	95.90%-10.04M	102.43%1.35M	99.47%-111K	102.84%460K	92.29%-11.74M	-183.16%-245.03M	76.83%-55.48M
Cash from discontinued investing activities
Operating cash flow	-10.21%-37.35M	-14.83%-33.93M	-22.01%-32.4M	6.69%-103.76M	49.34%-13.77M	-14.12%-33.89M	2.56%-29.55M	-10.64%-26.56M	-121.67%-111.19M	53.80%-27.17M
Investing cash flow
Cash flow from continuing investing activities	-503.16%-91.49M	-18.81%16.32M	-119.60%-69.6M	116.29%72.66M	113.83%61.56M	21,712.38%22.69M	4,011.09%20.1M	-9,712.38%-31.69M	-35,814.81%-446.06M	-276,372.05%-445.12M
Net PPE purchase and sale	87.48%-94K	36.86%-442K	-694.12%-945K	-216.20%-2.97M	-1,093.16%-1.4M	-804.82%-751K	-36.99%-700K	47.58%-119K	20.58%-938K	27.78%-117K
Net investment purchase and sale	-488.47%-91.4M	-19.42%16.76M	-117.43%-68.66M	117.02%75.72M	114.15%62.97M	--23.53M	--20.8M	---31.58M	---445M	---445M
Net other investing changes	----	----	----	17.50%-99K	-1,700.00%-16K	----	----	----	-96.72%-120K	0.00%1K
Cash from discontinued investing activities
Investing cash flow	-503.16%-91.49M	-18.81%16.32M	-119.60%-69.6M	116.29%72.66M	113.83%61.56M	21,712.38%22.69M	4,011.09%20.1M	-9,712.38%-31.69M	-35,814.81%-446.06M	-276,372.05%-445.12M
Financing cash flow
Cash flow from continuing financing activities	-4,520.00%-442K	56,035.78%122.38M	-96.19%22K	-43.90%1.11M	-77.66%307K	1,100.00%10K	-21.58%218K	73.57%578K	-45.78%1.98M	-41.68%1.37M
Net common stock issuance	--0	----	----	----	----	----	----	----	----	----
Proceeds from stock option exercised by employees	360.00%46K	992.66%2.38M	-96.19%22K	20.32%1.11M	-2.54%307K	1,100.00%10K	-21.58%218K	73.57%578K	-68.57%925K	-80.79%315K
Net other financing activities	----	----	----	----	----	----	----	----	47.91%1.06M	----
Cash from discontinued financing activities
Financing cash flow	-4,520.00%-442K	56,035.78%122.38M	-96.19%22K	-43.90%1.11M	-77.66%307K	1,100.00%10K	-21.58%218K	73.57%578K	-45.78%1.98M	-41.68%1.37M
Net cash flow
Beginning cash position	16.13%251.4M	-34.88%146.92M	-11.78%251.45M	-66.42%285.04M	-72.84%204.4M	-72.67%216.48M	-72.63%225.6M	-66.42%285.04M	152.29%848.84M	-16.38%752.47M
Current changes in cash	-1,055.65%-129.28M	1,235.73%104.77M	-76.83%-101.98M	94.60%-29.99M	110.21%48.1M	62.46%-11.19M	69.81%-9.23M	-140.38%-57.67M	-207.70%-555.27M	-731.70%-470.92M
Effect of exchange rate changes	316.20%1.94M	-358.04%-289K	-44.21%-2.55M	57.75%-3.6M	-130.05%-1.05M	90.94%-895K	107.13%112K	-214.56%-1.77M	-168.45%-8.53M	-37.18%3.49M
End cash Position	-39.31%124.05M	16.13%251.4M	-34.88%146.92M	-11.78%251.45M	-11.78%251.45M	-72.84%204.4M	-72.67%216.48M	-72.63%225.6M	-66.42%285.04M	-66.42%285.04M
Free cash flow	-8.09%-37.45M	-13.63%-34.37M	-25.01%-33.35M	4.82%-106.72M	44.44%-15.16M	-16.33%-34.64M	1.90%-30.25M	-10.09%-26.67M	-121.90%-112.13M	53.73%-27.29M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Audit Opinions	--	--	--	--	--	--	--	--	Unqualified Opinion	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data